A multicenter, phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma

Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications

Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181 · see citing works

A review of magnet systems for targeted drug delivery

Liu, Y.-L., Chen, D., Shang, P., & Yin, D.-C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.031 · Cited by 298 · see citing works

Magnetic nanoparticles: a novel platform for cancer theranostics

Singh, A., & Sahoo, S. K. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.005 · Cited by 289 · see citing works

Magnetic Iron Oxide Nanoparticles As Drug Carriers: Clinical Relevance

El‐Boubbou, K. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0336 · Cited by 203 · see citing works

Magnetic Micro- and Nano-Particle-Based Targeting for Drug and Gene Delivery

Dobson, J. (2006) · Nanomedicine · doi:10.2217/17435889.1.1.31 · Cited by 196 · see citing works

Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite—Initial Experience with Four Patients

Wilson, M. W., Kerlan, R. K., Fidelman, N. A., Venook, A. P., LaBerge, J. M., Koda, J., & Gordon, R. L. (2004) · Radiology · doi:10.1148/radiol.2301021493 · Cited by 190 · see citing works

Open challenges in magnetic drug targeting

Shapiro, B., Kulkarni, S. D., Nacev, A., Muro, S., Stepanov, P. Y., & Weinberg, I. N. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1311 · Cited by 173 · see citing works

Physical triggering strategies for drug delivery

Sun, T., Dasgupta, A., Zhao, Z., Nurunnabi, M., & Mitragotri, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.010 · Cited by 115 · see citing works

Advanced targeted nanomedicine

Arachchige, M. C. M., Reshetnyak, Y. K., & Andreev, O. A. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.01.009 · Cited by 67 · see citing works

The State of the Art of Natural Polymer Functionalized Fe3O4 Magnetic Nanoparticle Composites for Drug Delivery Applications: A Review

Nordin, A. H., Ahmad, Z., Husna, S. M. N., Ilyas, R. A., Azemi, A. K., Ismail, N., Nordin, M. L., Ngadi, N., Siti, N. H., Nabgan, W., et al. (2023) · Gels · doi:10.3390/gels9020121 · Cited by 62 · see citing works

Magnetic targeting and ultrasound mediated drug delivery: Benefits, limitations and combination

Owen, J., Pankhurst, Q. A., & Stride, E. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2012.668639 · Cited by 62 · see citing works

Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications

Etemadi, H., Buchanan, J. K., Kandile, N. G., & Plieger, P. G. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00938 · Cited by 52 · see citing works

Numerical simulations of targeted delivery of magnetic drug aerosols in the human upper and central respiratory system: a validation study

Kenjereš, S., & Tjin, J. L. (2017) · Royal Society Open Science · doi:10.1098/rsos.170873 · Cited by 44 · see citing works

Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles

Ma, H., Qi, X., Ding, W., Maitani, Y., & Nagai, T. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31346 · Cited by 39 · see citing works

Superparamagnetic iron oxide nanoparticles for drug delivery

Chee, C. F., Leo, B. F., & Lai, C. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813741-3.00038-8 · Cited by 33 · see citing works

Coating Nanomagnetic Particles for Biomedical Applications

Andrade, Â. L., Ferreira, R. V., Fabris, J. D., & Domingues, R. Z. (2011) · InTech eBooks · doi:10.5772/19519 · Cited by 28 · see citing works

Magnetic Microparticles for Endovascular Aneurysm Treatment: In Vitro and In Vivo Experimental Results

Oechtering, J., Kirkpatrick, P. J., Ludolph, A., Hans, F. J., Sellhaus, B., Spiegelberg, A., & Krings, T. (2011) · Neurosurgery · doi:10.1227/neu.0b013e3182125eb0 · Cited by 20 · see citing works

Magnetically Vectored Platforms for The Targeted Delivery of Therapeutics to Tumors: History and Current Status

Seeney, C. E., Ojwang, J. O., Weiss, R. D., & Klostergaard, J. (2012) · Nanomedicine · doi:10.2217/nnm.11.183 · Cited by 17 · see citing works

On-chip testing of the speed of magnetic nano- and micro-particles under a calibrated magnetic gradient

Benhal, P., Broda, A., Najafali, D., Malik, P., Mohammed, A. M., Ramaswamy, B., Depireux, D. A., Shimoji, M., Shukoor, M. I., & Shapiro, B. (2018) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2018.10.148 · Cited by 17 · see citing works

Cytotoxicity and uptake analysis of Mn-Zn ferrite-based temperature-sensitive ferrofluid on cervical and bone cancer cells

Shah, K., Bhardwaj, A., Bhadla, D., Parekh, K. H., & Jain, N. D. (2023) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2023.171534 · Cited by 13 · see citing works

The role of tumor model in magnetic targeting of magnetosomes and ultramagnetic liposomes

Curcio, A., Perez, J. E., Prévéral, S., Fromain, A., Genevois, C., Michel, A., de Walle, A. V., Lalatonne, Y., Faivre, D., Ménager, C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28914-4 · Cited by 13 · see citing works

Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours

Patel, P., Alghamdi, A. S. A., Shaw, G. C., et al. (2022) · Nanotheranostics · doi:10.7150/ntno.76559 · Cited by 11 · see citing works

Preparation and characterization of magnetic nanoparticles and their impact on anticancer drug binding and release processes moderated through a 1 st tier dendrimer

Pandya, S. R., & Singh, M. (2016) · RSC Advances · doi:10.1039/c6ra02139e · Cited by 9 · see citing works

Nanomaterials: Versatile Drug Carriers for Nanomedicine

Shinde, A. S., Shinde, P., & Santra, T. S. (2021) · Springer series in biomaterials science and engineering · doi:10.1007/978-981-33-6252-9_10 · Cited by 10 · see citing works

Core–Shell Magnetic Nanomaterials in Medical Diagnosis and Therapy

Melancon, M. P., & Li, C. (2009) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0169 · Cited by 3 · see citing works

Magnetic Nanoparticles as Drug Delivery Devices

Agotegaray, M., & Lassalle, V. (2017) · Springer briefs in molecular science · doi:10.1007/978-3-319-50158-1_2 · Cited by 3 · see citing works

Magnetic Nanoparticles in Magnetic Resonance Imaging and Drug Delivery

Sutphin, P. D., Flores, E. J., & Harisinghani, M. G. (2011) · doi:10.1002/9783527634057.ch8 · Cited by 2 · see citing works

Design and Development of pH Sensitive Nanomedicine for Targeted Drug Delivery

Pereira, M. C. (2016) · doi:10.23860/diss-pereira-mohan-2016

Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor

Feng, C., Li, J., Mu, Y., Kong, M., Li, Y., Raja, M. A., Cheng, X. J., Liu, Y., & Chen, X. G. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.012 · Cited by 31 · see citing works

Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes

Vaage, J., Donovan, D., Mayhew, E. G., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540616 · Cited by 67 · see citing works

Novel nanostructured enoxaparin sodium-PLGA hybrid carriers overcome tumor multidrug resistance of doxorubicin hydrochloride

Wang, J., Wu, L., Kou, L., Xu, M. J., Sun, J., Wang, Y., Fu, Q., Zhang, P., & He, Z. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.037 · Cited by 13 · see citing works

[Synthesis and antitumor properties of 3'-desamino- dimethylformamidine doxorubicin].

Ul'ianova, L. A., Tarasova, V. E., Shepelevtseva, N. G., et al. (1989) · PubMed

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib

Dika, I. E., Capanu, M., Chou, J. F., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3389 · Cited by 16 · see citing works